BCAB logo
BCAB NASDAQ US

BioAtla, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Dec 2020
$0.13
▼ $-0.01 (-3.70%)
Vol 1.1M
3
Quality Score
fail
Mkt Cap
$33.5M
ROE
-235.9%
Margin
-96.2%
D/E
0.00
Beta
1.08
52W
$0–$1

Wall Street Consensus

7 analysts · Apr 2026
3
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

IMNN
Imunon Inc
$11.7M
CLRB
Cellectar Biosciences Inc
$12.5M
BIVI
BioVie Inc
$8.7M
ACXP
Acurx Pharmaceuticals Inc
$5.8M
LNAI
Lunai Bioworks Inc
$20.7M
BOLT
Bolt Biotherapeutics Inc
$10.5M
APRE
Aprea Therapeutics Inc
$6.0M

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.24 $-0.16 +$0.08
Sep 2025 $-0.30 $-0.27 +$0.03
Jun 2025 $-0.34 $-0.32 +$0.02
Mar 2025 $-0.35 $-0.26 +$0.09

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) — -235.9% -235.9% -235.9% -235.9% -235.9%
P/E (TTM) — — — — — —
Net Margin — -96.2% -96.2% -96.2% -96.2% -96.2%
Gross Margin — — — — — —
D/E Ratio — 0.00 0.00 0.00 0.00 0.00
Current Ratio 1.24 1.24 1.24 1.24 1.24 0.54

Key Ratios

ROA (TTM)
-89.8%
P/S (TTM)
3.05
P/B
2.4
EPS (TTM)
$-0.57
CF/Share
$-2.64
Rev Growth 3Y
+194.7%
52W High
$1.43
52W Low
$0.24
$0.24 52-Week Range $1.43

How does BCAB compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

BCAB AAPG ABEO ABOS ABP

BCAB valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
3.1
▼ 76% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
2.4
▼ 2% below peers (2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

BCAB profitability vs Biotechnology peers

ROE
-235.9%
▼ 251% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-96.2%
▲ 66% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-89.8%
▼ 92% below peers (-46.7%)
vs Peers
vs Industry
Weak

BCAB financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
0.5
▼ 88% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.1
▲ 12% above peers (1.0)
vs Peers
vs Industry
Less volatile

BCAB fundamentals radar

BCAB Peer median Industry

BCAB profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

BCAB vs peers: key metrics

Latest News

No related news yet